Del Giudice Matthew Paul 4
4 · Telomir Pharmaceuticals, Inc. · Filed Aug 29, 2024
Insider Transaction Report
Form 4
Del Giudice Matthew Paul
Director
Transactions
- Award
Incentive Stock Options (right to buy)
2024-08-27+25,000→ 25,000 totalExercise: $5.02Exp: 2034-08-27→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 26, 2024.
- [F2]The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the "Plan"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025.